PHUONG-THAO NGUYEN: Open Payments
NPI 1538870787 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 16 payments from 6 companies in 2025. Trend: 2023 $961 · 2024 $2,103 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $246 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $116 |
| Vanda Pharmaceuticals Inc. | 3 | $95 |
| Lundbeck LLC | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Alkermes, Inc. | 1 | $25 |
Products named: VRAYLAR, CAPLYTA, REXULTI, HETLIOZ, ARISTADA.
Industry payments across CA — which companies pay providers there.
